Comparative antibacterial activity of the new oral monobactam tigemonam (SQ 30836) against urinary isolates.
Cocuzza
G
G
Institute of Medical Microbiology, University of Milano, via Mangiagalli 31, Milano, Italy.
Raimondi
A
A
D000150:Acinetobacter / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D005417:Flavobacterium / Q000187:drug effects; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D008997:Monobactams / Q000494:pharmacology*; D011549:Pseudomonas / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D014552:Urinary Tract Infections / Q000652:urine*; D014556:Urine / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D008997:Monobactams; C052020:tigemonam